Author

Nicolas Garcelon

InsermORCID 0000-0002-3326-2811Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Assay:proteomics· 1 Research Focus:variant effect prediction· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Adel Abderrahmane· 1 shared Agathe GuillouxiD· 1 shared Alejandro Garcia· 1 shared Alexandre BenmerahiD· 1 shared Anita BurguniD· 1 shared Antoine FavieriD· 1 shared Antonio RauselliD· 1 shared Baptiste LamarthéeiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

Adel Abderrahmane

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Non-HLA antibodies worsen the histological phenotype and prognosis of antibody mediated rejection in kidney allografts

Emilie Lebraud, Olivier Aubert, Laïla Aouni, Virginia Garcia, Lise Morin, Maëva Eloudzeri, Baptiste Lamarthée, Julien Zuber, Corentin Ramaugé Parra, Mélanie Try, Maarten Coemans, Dirk R. J. Kuypers, Karolien Wellekens, Tim Debyser, Priyanka Koshy Lehnert, , Dany Anglicheau

This study shows non-HLA antibodies are linked to worse histology and graft outcomes in kidney transplant patients with antibody-mediated rejection, especially when combined with HLA-DSAs.

Kidney International · Jul 25, 2026Peer-reviewedPathology

COBT: A gene-based rare variant burden test for case-only study designs using aggregated genotypes from public reference cohorts.

Antoine Favier, Stefania Chounta, Alejandro Garcia, Fabienne Jabot‐Hanin, Xiaoyi Chen, Nicolas Garcelon, Anita Burgun, Manuel Higueras, Agathe Guilloux, Alexandre Benmerah, Yoann Martin, Katy Billot, Jean‐Michel Rozet, Isabelle Perrault, Valérie Cormier‐Daire, , Antonio Rausell

COBT is a gene-based rare variant burden test for case-only studies that outperforms existing methods and identifies novel candidate variants in rare diseases.

Genome Medicine · Mar 24, 2026Peer-reviewedGenetic & Genomic Medicine